| Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149) |
|---|
| 12/26/2007 | CN101094835A Novel dicarboxamide derivatives |
| 12/26/2007 | CN100357281C Bicyclic compounds, process for their preparation and pharmaceutical composition containing them |
| 12/25/2007 | US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis |
| 12/21/2007 | CA2653039A1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 12/20/2007 | US20070293483 Acetyl 2-hydroxy-1, 3-diaminoalkanes |
| 12/19/2007 | CN101090897A Novel fused ring compounds, and their use as cationic photoinitiators |
| 12/13/2007 | WO2006079720A8 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents |
| 12/13/2007 | US20070287843 Methods and Intermediates for the Synthesis of Delta-9 Tetrahydrocannabinol |
| 12/13/2007 | US20070287699 Antiviral agents |
| 12/12/2007 | CN101087773A Inhibitors of c-fms kinase |
| 12/11/2007 | US7307076 Beta agonists for the treatment of respiratory diseases |
| 12/06/2007 | WO2007139002A1 Method for producing nitrogen-containing fused ring compound |
| 12/06/2007 | WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound |
| 12/06/2007 | WO2007138242A1 Biphenyl derivatives and their use in treating hepatitis c |
| 12/06/2007 | US20070282100 Boronic ester and acid compounds, synthesis and uses |
| 12/06/2007 | CA2653924A1 Biphenyl derivatives and their use in treating hepatitis c |
| 12/05/2007 | CN101084204A Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC) |
| 12/04/2007 | US7304057 Substituted 6-membered N-heterocyclic compounds and method for their use as neurological regulator |
| 11/29/2007 | US20070276011 Plasminogen Activator Inhibitor-1 Inhibitor |
| 11/29/2007 | US20070275956 Novel Heterocyclic Compounds |
| 11/22/2007 | WO2007133800A2 Toll-like receptor (tlr) stimulation for ocular angiogenesis and macular degeneration |
| 11/22/2007 | WO2007110627A3 3,7-diamino-10h-phenothiazine salts and their use |
| 11/22/2007 | US20070270379 Inclusion Complexes Containing Piroxicam, a Cyclodextrin and Arginine |
| 11/22/2007 | CA2651817A1 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors |
| 11/21/2007 | EP1857104A1 Use of cinnamoyl compound |
| 11/15/2007 | US20070265253 non-steroidal antiinflammatory agents such as 4H-Pyrido[2,3-g][1,4]benzothiazine-5,10-dione-1,1-dioxo-7-carboxylic acid, useful for treating inflammatory diseases or disorders |
| 11/15/2007 | US20070265252 modulator of cholesteryl ester transfer protein (CETP), such as 1,1,1-Trifluoro-3-[3-[3-(1,1,2,2-tetrafluoro-ethoxy)-phenyl]-8-(3-trifluoromethoxy-phenyl)-2,3-dihydro-benzo[1,4]oxazin-4-yl]-propan-2-ol, used for treating cardiovascular disorders, dyslipidemia, and metabolic disorders |
| 11/15/2007 | US20070265202 Compounds That Modulate Trh Actions |
| 11/13/2007 | CA2248304C Surface modified carbonate materials |
| 11/08/2007 | US20070259852 Such as 2-(2-hydroxycarbamoylmethyl-3-oxo-2,3-dihydro-benzo[1,4]thiazin-4-yl)-propionamide; peptidyl deformylase (PDF) inhibitors; for treatment of bacterial infections |
| 11/06/2007 | CA2263927C Heterocyclic thioesters and ketones |
| 11/01/2007 | WO2007123516A1 C-fms kinase inhibitors |
| 11/01/2007 | US20070254872 Antibacterial Agents |
| 11/01/2007 | CA2649512A1 C-fms kinase inhibitors |
| 10/31/2007 | EP1687638B1 Analysis of mass spectral data in the quiet zones |
| 10/31/2007 | CN100345832C Phenothiazines in prill form |
| 10/30/2007 | US7288676 Arylphenyl-substituted cyclic ketoenols |
| 10/25/2007 | WO2006047759A3 Kinase inhibitors for the treatment of diabetes and obesity |
| 10/25/2007 | US20070249594 Benzothiazine and benzothiadiazine compounds |
| 10/17/2007 | EP1844029A1 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents |
| 10/16/2007 | US7282584 Methylene blue |
| 10/16/2007 | US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents |
| 10/09/2007 | US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 10/09/2007 | US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 10/04/2007 | WO2007110627A2 3,7-diamino-10h-phenothiazine salts and their use |
| 09/27/2007 | US20070225495 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis |
| 09/26/2007 | EP1699752B1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
| 09/19/2007 | CN101037422A Phenothiazine double-photon photoacid initiator and preparation method thereof |
| 09/18/2007 | CA2177143C Metal chelate containing compositions for use in chemiluminescent assays |
| 09/13/2007 | WO2007082208A3 Lanthionine-related compounds for the treatment of inflammatory diseases |
| 09/13/2007 | US20070213526 5-(2-thioxospiro[cyclohexane-1,3-[3H]-indol]-1-methyl-2-pyrrole-2-carbonitrile; treating with base in presence of solvent to form basic salt and converting it to purified form by treating with water, acid, or heat |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/12/2007 | CN101035776A Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 08/30/2007 | US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/29/2007 | CN101024633A Tricyclic arylamine monomer and polymers and devices thereof |
| 08/28/2007 | US7262189 Cognition activators; neurodegenerative diseases; anxiolytic agents;psychological disorders; alzheimer's disease; Huntington's disease; antiischemic agents; antiepileptic agenst |
| 08/28/2007 | US7261952 Red color emitting compounds for organic electroluminescent device and an organic electroluminescent device using them |
| 08/23/2007 | WO2007093507A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 08/23/2007 | US20070197515 lanthionine ketimine derivatives and thiomorpholine dicarboxylic acid derivatives; can pass through blood-brain barrier; has -oxidant, anti-neuroinflammatory and neuroprotective activities; cancer,Parkinson's disease, Huntington's disease, multiple sclerosis |
| 08/23/2007 | US20070197514 Conjugates with organic acids; uses thereof in the treatment of psychotic and/or proliferative disorders and diseases and as chemosensitizing agents; the organic acids are selected to reduce side effects induced by the psychotropic drugs and/or to exert an anti-proliferative activity |
| 08/23/2007 | US20070197512 Carboxylic Acid Compounds and Use Thereof |
| 08/16/2007 | US20070191352 Prophylaxis, therapy of Alzheimer's disease, Pick's disease; administering phenothiazine compound such as methylene blue |
| 08/14/2007 | US7256197 Methods for synthesis of diarylmethanes |
| 08/14/2007 | US7256186 Alzheimer's disease, or other diseases relating to amyloid deposits; neurodegenerative diseases |
| 08/14/2007 | US7256158 Animal husbandry; veterinary medicine |
| 08/09/2007 | WO2007089034A1 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 08/08/2007 | CN1330614C Diphenyl anthracene derivate and organic electroluminescent apparatus using diphenyl anthracene derivate |
| 08/07/2007 | US7253279 Method for inhibiting polymerization of (METH) acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor |
| 08/07/2007 | US7253198 Hydroxyethylamine derivatives for the treatment of Alzheimer's disease |
| 08/07/2007 | US7253196 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| 08/07/2007 | US7253164 1,4-benzothiazin-3-one derivatives that are optionally S-mono- or dioxygenated; peptide deformylase inhibitors, used for treating bacterial infections |
| 08/07/2007 | US7253161 Cognition activators; neurodegenerative disease; anxiolytic agents; Alzheimer's diseas; Pick's disease; schizophrenia; psychological disorders; antiischemic agents; antiepileptic agents; antidepressants |
| 08/02/2007 | WO2007086504A1 Carboxylic acid compound and use thereof |
| 08/02/2007 | WO2007070760A3 Compounds which modulate the cb2 receptor |
| 08/02/2007 | WO2006131923A3 Novel salts of conjugated psychotropic drugs and processes of preparing same |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/01/2007 | EP1812425A2 C-fms kinase inhibitors |
| 08/01/2007 | EP1812412A1 Substituted benzoylguanidines method for production and use thereof as medicament or diagnostic and medicament comprising the same |
| 08/01/2007 | EP1812078A2 Kinase inhibitors for the treatment of diabetes and obesity |
| 07/31/2007 | US7250412 Diisopropylphenyl esters of N-amino- or N-heterocyclyl-alkanamic acids, e.g., N-(2-Piperidin-1-yl-ethyl)-succinamic acid 2,6-diisopropylphenyl ester; induction and maintenance of anesthesia or sedation |
| 07/31/2007 | US7250411 Benzothiazine and benzothiadiazine compounds |
| 07/31/2007 | CA2069145C Assay method utilizing induced luminescence |
| 07/25/2007 | EP1810290A2 Changing light absorption by disruption of conjugation |
| 07/25/2007 | EP1534346A4 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |
| 07/25/2007 | EP1282610B1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/19/2007 | WO2007082208A2 Lanthionine-related compounds for the treatment of inflammatory diseases |
| 07/19/2007 | US20070167444 Benzamide derivative or salt thereof |
| 07/19/2007 | CA2636042A1 Lanthionine-related compounds for the treatment of inflammatory diseases |
| 07/18/2007 | EP1807406A2 Inhibitors of c-fms kinase |
| 07/17/2007 | US7245073 Quinoxaline derivatives, and light emitting element using thereof |
| 07/17/2007 | US7244725 treatment of Alzheimer's disease and more specifically compounds that are capable of inhibiting beta-secretase |
| 07/12/2007 | US20070161697 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 07/12/2007 | US20070161625 phenothiazinium compounds; for healing process and cosmetic uses; for problems associated with vascular disease, malnutrition, stress, cancer radio- or chemotherapy, compromise of immune system or due to normal aging process; as a cream, suspension, emulsion, gel, ointment, salve, stick, soap, paste |
| 07/11/2007 | CN1997400A Conjugated psychotropic drugs and uses thereof |
| 07/11/2007 | CN1994298A Carbamate aspartic acid specific cysteine proteinase inhibitors and uses thereof |
| 07/10/2007 | US7241888 Process for preparing 10α-[4′-(S,S-dioxothiomorpholin-1′-yl)]-10-deoxo-10-dihydroartemisinin |
| 07/04/2007 | EP1802595A1 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 07/04/2007 | EP1456189B1 Benzothia(dia)zine derivatives and their use as ampa modulators |
| 07/03/2007 | US7238811 Chemical compounds |